IL-6 receptor inhibition with tocilizumab improves treatment outcomes in patients with rheumatoid arthritis refractory to anti-tumour necrosis factor biologicals: results from a 24-week multicentre randomised placebo-controlled trial
Paul Emery, Edward Keystone, Hans‐Peter Tony, Alain Cantagrel, Ronald van Vollenhoven, Antonio Sánchez, Emma Alecock, J. Lee, Joel M. Kremer
Annals of the Rheumatic Diseases, 2008
Abstract
This research paper explore the methodology and findings associated with Annals of the Rheumatic Diseases. The study delves into the core aspects of the research field, providing significant data and citation impact. (Full abstract processing is available via the OpenAlex API).